SNHG18 inhibits bladder cancer cell proliferation by increasing p21 transcription through destabilizing c-Myc protein.
Bladder cancer
SNHG18
c-Myc
lncRNA
p21
Journal
Cancer cell international
ISSN: 1475-2867
Titre abrégé: Cancer Cell Int
Pays: England
ID NLM: 101139795
Informations de publication
Date de publication:
16 Mar 2023
16 Mar 2023
Historique:
received:
16
12
2022
accepted:
03
03
2023
entrez:
17
3
2023
pubmed:
18
3
2023
medline:
18
3
2023
Statut:
epublish
Résumé
Long non-coding RNAs (lncRNAs) have been confirmed to play important roles in various cancers including bladder cancer (BC). The precise expression pattern of lncRNA small nucleolar RNA host gene 18 (SNHG18) in BC and its mechanisms of action have not been fully explored. The expression of SNHG18 was evaluated by RT-qPCR in bladder cancer clinical samples and human bladder cancer cell lines, and stable cell lines overexpressing SNHG18 were constructed. The effect of SNHG18 on the proliferation of bladder cancer cells was detected by soft agar colony formation test, ATP activity test and subcutaneous tumorigenesis model in nude mice. The specific mechanism of SNHG18 inhibition of bladder cancer proliferation was studied by flow cytometry, western blotting, dual luciferase reporter gene assay and protein degradation assay. We found that SNHG18 is significantly downregulated in BC tissues and cell lines. Kaplan-Meier analysis showed that SNHG18 expression is positively correlated with survival in BC patients. Ectopic overexpression of SNHG18 significantly inhibited the proliferation of BC cells in vitro and in vivo. Further mechanistic investigations demonstrated that SNHG18 inhibited c-Myc expression by modulating the ubiquitination-proteasome pathway and that c-Myc is the critical transcription factor that mediates SNHG18 inhibition of BC growth by directly binding to the p21 promoter, which was attributed with significant p21 accumulation. SNHG18 promotes the transcription and expression of p21 by inhibiting c-Myc expression, leading to G0-G1 arrest and inhibiting the proliferation of bladder cancer cells. These findings highlight a novel cell cycle regulatory mechanism involving the SNHG18/c-Myc/p21 pathway in BC pathogenesis and could potentially lead to new lncRNA-based diagnostics and/or therapeutics for BC.
Sections du résumé
BACKGROUND
BACKGROUND
Long non-coding RNAs (lncRNAs) have been confirmed to play important roles in various cancers including bladder cancer (BC). The precise expression pattern of lncRNA small nucleolar RNA host gene 18 (SNHG18) in BC and its mechanisms of action have not been fully explored.
MATERIALS AND METHODS
METHODS
The expression of SNHG18 was evaluated by RT-qPCR in bladder cancer clinical samples and human bladder cancer cell lines, and stable cell lines overexpressing SNHG18 were constructed. The effect of SNHG18 on the proliferation of bladder cancer cells was detected by soft agar colony formation test, ATP activity test and subcutaneous tumorigenesis model in nude mice. The specific mechanism of SNHG18 inhibition of bladder cancer proliferation was studied by flow cytometry, western blotting, dual luciferase reporter gene assay and protein degradation assay.
RESULTS
RESULTS
We found that SNHG18 is significantly downregulated in BC tissues and cell lines. Kaplan-Meier analysis showed that SNHG18 expression is positively correlated with survival in BC patients. Ectopic overexpression of SNHG18 significantly inhibited the proliferation of BC cells in vitro and in vivo. Further mechanistic investigations demonstrated that SNHG18 inhibited c-Myc expression by modulating the ubiquitination-proteasome pathway and that c-Myc is the critical transcription factor that mediates SNHG18 inhibition of BC growth by directly binding to the p21 promoter, which was attributed with significant p21 accumulation.
CONCLUSIONS
CONCLUSIONS
SNHG18 promotes the transcription and expression of p21 by inhibiting c-Myc expression, leading to G0-G1 arrest and inhibiting the proliferation of bladder cancer cells. These findings highlight a novel cell cycle regulatory mechanism involving the SNHG18/c-Myc/p21 pathway in BC pathogenesis and could potentially lead to new lncRNA-based diagnostics and/or therapeutics for BC.
Identifiants
pubmed: 36927398
doi: 10.1186/s12935-023-02887-w
pii: 10.1186/s12935-023-02887-w
pmc: PMC10018893
doi:
Types de publication
Journal Article
Langues
eng
Pagination
48Subventions
Organisme : National Natural Science Foundation of China
ID : NSFC82272385
Informations de copyright
© 2023. The Author(s).
Références
Exp Cell Res. 1999 Feb 1;246(2):280-9
pubmed: 9925742
Int Braz J Urol. 2019 May-Jun;45(3):549-559
pubmed: 31038865
Cell Signal. 2010 Jul;22(7):1003-12
pubmed: 20100570
Proc Natl Acad Sci U S A. 2004 Jun 15;101(24):9085-90
pubmed: 15150404
Mol Cancer. 2019 Dec 2;18(1):174
pubmed: 31791342
Cancer Gene Ther. 2018 Feb;25(1-2):10-17
pubmed: 29234154
Gastroenterology. 2018 Jun;154(8):2137-2151.e1
pubmed: 29454790
Cell Death Dis. 2021 Nov 2;12(11):1043
pubmed: 34728613
Int J Radiat Oncol Biol Phys. 2016 Nov 15;96(4):877-887
pubmed: 27788958
EMBO J. 2005 Jan 26;24(2):336-46
pubmed: 15616584
J Biol Chem. 2014 Mar 7;289(10):6394-6403
pubmed: 24451377
Cancer Res. 2005 May 15;65(10):3980-5
pubmed: 15899785
Int J Cancer. 1998 Aug 21;79(4):424-8
pubmed: 9699537
Genes (Basel). 2019 Mar 22;10(3):
pubmed: 30909496
Br J Cancer. 2003 Nov 3;89(9):1757-65
pubmed: 14583781
J Biol Chem. 2005 May 6;280(18):17617-25
pubmed: 15757889
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
Aging (Albany NY). 2019 Nov 18;11(22):10144-10153
pubmed: 31739288
Biochim Biophys Acta. 2015 May;1849(5):506-16
pubmed: 24704206
Nucleic Acids Res. 2016 Apr 7;44(6):2846-58
pubmed: 26861625
FASEB J. 2019 Oct;33(10):11045-11059
pubmed: 31298933
J BUON. 2019 Nov-Dec;24(6):2242-2244
pubmed: 31983089
Trends Cell Biol. 2017 Jan;27(1):69-81
pubmed: 27746095
Nature. 2012 Sep 6;489(7414):57-74
pubmed: 22955616
Oncotarget. 2014 Jan 30;5(2):493-505
pubmed: 24457827
Neoplasma. 2018 Nov 15;65(6):925-932
pubmed: 29940769
Nature. 2017 Nov 8;551(7679):S34-S35
pubmed: 29117159
Biochem Biophys Res Commun. 2018 Sep 10;503(3):1825-1829
pubmed: 30060954
ACS Chem Biol. 2012 Apr 20;7(4):678-82
pubmed: 22276948
Nature. 2002 Oct 17;419(6908):729-34
pubmed: 12384701
Front Genet. 2019 Nov 13;10:1140
pubmed: 31798634
Int J Oncol. 2018 Nov;53(5):2021-2033
pubmed: 30226575
Eur Urol. 2018 Dec;74(6):784-795
pubmed: 30268659
Trends Cell Biol. 2003 Feb;13(2):65-70
pubmed: 12559756
Nat Genet. 2013 Oct;45(10):1113-20
pubmed: 24071849
J Cell Biochem. 2019 Aug;120(8):13487-13493
pubmed: 30916832
Oncogene. 2003 Jan 23;22(3):351-60
pubmed: 12545156
Mol Cancer. 2018 Oct 3;17(1):143
pubmed: 30285771
Int J Mol Sci. 2020 Nov 12;21(22):
pubmed: 33198081
Technol Cancer Res Treat. 2018 Jan 1;17:1533033818794494
pubmed: 30126319
Cancer Lett. 2020 Aug 10;485:38-44
pubmed: 32437725
Cell Death Dis. 2021 Jan 26;12(1):128
pubmed: 33500406
Acta Haematol. 2020;143(3):279-288
pubmed: 31597158
Nat Rev Cancer. 2009 Jun;9(6):400-14
pubmed: 19440234